Boston Financial Statements From 2010 to 2024
| BSX Stock | EUR 86.50 0.50 0.58% |
Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as , as well as many indicators such as . Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
Boston |
Boston Scientific Company Operating Margin Analysis
Boston Scientific's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Boston Scientific Operating Margin | 0.16 % |
Most of Boston Scientific's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boston Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Boston Scientific has an Operating Margin of 0.1603%. This is 100.46% lower than that of the Healthcare sector and 100.41% lower than that of the Medical Devices industry. The operating margin for all Germany stocks is 102.91% lower than that of the firm.
Boston Scientific Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Boston Scientific's current stock value. Our valuation model uses many indicators to compare Boston Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boston Scientific competition to find correlations between indicators driving Boston Scientific's intrinsic value. More Info.Boston Scientific is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.96 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Boston Scientific is roughly 1.04 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Boston Scientific's earnings, one of the primary drivers of an investment's value.About Boston Scientific Financial Statements
Boston Scientific stakeholders use historical fundamental indicators, such as Boston Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Although Boston Scientific investors may analyze each financial statement separately, they are all interrelated. For example, changes in Boston Scientific's assets and liabilities are reflected in the revenues and expenses on Boston Scientific's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENTIFIC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38000 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Boston Stock
Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.